Listed

BridgeBio Pharma, Inc.

BBIONasdaqCIK 1743881HealthcareFiscal year ends Dec 31

Reports and events: 183 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

BridgeBio Pharma, Inc., Reports and events
FiledFormWhat it isAccession number
2022-04-2916:05 ETDEF 14AProxy statementPeriod 2022-06-220001193125-22-133557
2022-02-2506:06 ET10-KAnnual reportPeriod 2021-12-310000950170-22-002030
2022-02-2407:38 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-22-051102
2021-12-2707:06 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-21-366669
2021-12-1606:41 ET8-K5.07 Shareholder vote results0001193125-21-358518
2021-11-1808:00 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-21-333214
2021-11-0817:22 ETDEF 14AProxy statementPeriod 2021-12-150001193125-21-323214
2021-11-0416:21 ET10-QQuarterly reportPeriod 2021-09-300000950170-21-003080
2021-11-0407:37 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-21-319331
2021-10-2606:08 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-21-307134
2021-08-2317:31 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-21-254149
2021-08-1316:48 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-21-246183
2021-08-0516:49 ET10-QQuarterly reportPeriod 2021-06-300001564590-21-041676
2021-06-2216:31 ET8-K5.07 Shareholder vote results0001193125-21-196269
2021-06-0107:41 ET8-K9.01 Financial statements and exhibits0001193125-21-177835
2021-05-1417:30 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-21-162215
2021-05-1117:07 ET8-K8.01 Other events0001193125-21-157729
2021-05-0616:38 ET10-QQuarterly reportPeriod 2021-03-310001564590-21-025064
2021-04-3017:05 ETDEF 14AProxy statementPeriod 2021-06-170001193125-21-145491
2021-04-1516:55 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation0001193125-21-117878
2021-03-3107:35 ET8-K8.01 Other events0001193125-21-101373
2021-02-2606:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-21-058156
2021-02-2517:25 ET10-KAnnual reportPeriod 2020-12-310001564590-21-008969
2021-02-1717:28 ETSC 13D/AOwnership report, active investor, amended0001140361-21-005265
2021-02-1716:16 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-21-046513
2021-01-2907:07 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-21-021591
2021-01-2616:56 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-21-017810
2021-01-2616:23 ETSC 13D/AOwnership report, active investor, amended0001193125-21-017733
2021-01-2609:00 ETSC 13D/AOwnership report, active investor, amended0001193125-21-017128
2021-01-2608:46 ET8-K2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-21-017108
2021-01-2016:19 ET8-K5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-21-012440
2021-01-1207:44 ET8-K8.01 Other events0001193125-21-006802
2021-01-0416:31 ET8-K5.02 Departure or appointment of officers or directors0001193125-21-001019
2020-11-0608:36 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001193125-20-287485
2020-11-0517:07 ET10-QQuarterly reportPeriod 2020-09-300001564590-20-051460
2020-11-0508:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-20-286266
2020-10-2316:30 ET8-K5.02 Departure or appointment of officers or directors0001193125-20-275507
2020-10-1516:17 ETSC 13DOwnership report, active investor0001193125-20-270273
2020-10-0617:18 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001193125-20-264837
2020-10-0616:45 ETSC 13D/AOwnership report, active investor, amended0001140361-20-022590
2020-10-0517:30 ETSC 13D/AOwnership report, active investor, amended0001193125-20-264026
2020-10-0517:19 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-20-263994
2020-09-2907:01 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-20-257161
2020-08-1117:18 ET10-QQuarterly reportPeriod 2020-06-300001564590-20-039358
2020-08-1108:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-20-215681
2020-06-2417:14 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-20-177774
2020-06-0816:05 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results0001193125-20-163454
2020-06-0117:09 ETSC 13D/AOwnership report, active investor, amended0001140361-20-012844
2020-05-1419:34 ET10-QQuarterly reportPeriod 2020-03-310001564590-20-025197
2020-05-1316:27 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-20-141632

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 12, 2026, 17:56 ET. Listed shows no prices and gives no investment advice.